Rubin Philip, Brasacchio Ralph, Katz Alan
Department of Radiation Oncology, James P. Wilmot Cancer Center at the University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Semin Radiat Oncol. 2006 Apr;16(2):120-30. doi: 10.1016/j.semradonc.2005.12.007.
"Suddenly a solitary horseman appeared on the horizon, then another, then another...in a few moments a whole crowd of horsemen swooped down upon him."-Leacock The illusion of solitary metastases is counterintuitive but has generated a sizable literature on the subject. The reality is that there are more metastatic deaths each year than the total number of true long-term survivors of solitary metastases combining all organ sites in the literature of the past century up to the present time. The largest number of solitary metastases survivors had metastases primarily in the lung and/or liver. With innovations in molecular imaging and advances in molecular oncology, the stage is set to detect truly solitary metastases early. Then, aggressive treatment by surgical excision, stereotactic body radiosurgery, targeted chemotherapy, or immunotherapy could eradicate the lesion. A comprehensive review of solitary metastases in a large variety of anatomic sites is presented. A broader staging system is recommended to encompass a solitary metastasis (M1) and oligometastases (M2) as distinct from multiple metastases (M3).
“突然,一名孤独的骑手出现在地平线上,接着又出现了一名,然后又是一名……片刻之间,一大群骑手向他猛扑过来。”——利科克 孤立性转移瘤的假象有违直觉,但已催生了大量关于该主题的文献。实际情况是,每年因转移瘤死亡的人数超过了过去一个世纪直至现在文献中所有器官部位孤立性转移瘤真正长期存活者的总数。孤立性转移瘤存活者数量最多的情况是转移瘤主要位于肺和/或肝脏。随着分子成像技术的创新和分子肿瘤学的进展,已具备早期检测真正孤立性转移瘤的条件。然后,通过手术切除、立体定向体部放射治疗、靶向化疗或免疫疗法进行积极治疗,有可能根除病灶。本文对多种解剖部位的孤立性转移瘤进行了全面综述。建议采用更广泛的分期系统,将孤立性转移瘤(M1)和寡转移瘤(M2)与多发转移瘤(M3)区分开来。